Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rama Pharma is a pharmaceutical company focused on commercialized medicines rather than novel biotech R&D. Based on its website, the company markets branded generic products in cardiovascular, allergy/respiratory, endocrine, and nutritional categories, including telmisartan-based antihypertensives, montelukast, levocetirizine, levothyroxine, and vitamin D products. The company emphasizes quality systems and states that its products are manufactured under GMP-compliant toll-manufacturing arrangements with Egyptian Group for Pharmaceutical Manufacturing Industries. Publicly available information suggests a modest commercial portfolio and limited evidence of a proprietary clinical pipeline. It appears to operate as an active healthcare company with commercial operations in Middle Eastern/North African markets and a registered UK legal entity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rama Pharma.